VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells-Reference-Cited by-同舟云学术

VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells

Published:2019-07 Issue:1 Volume:9 Page:74-92.e8
ISSN:2405-4712
Container-title:Cell Systems
language:en
Short-container-title:Cell Systems

Author:

Patterson Jesse C.,Joughin Brian A.,Prota Andrea E.,Mühlethaler Tobias,Jonas Oliver H.,Whitman Matthew A.,Varmeh Shohreh,Chen Sen,Balk Steven P.,Steinmetz Michel O.,Lauffenburger Douglas A.,Yaffe Michael B.

Funder

National Institutes of Health

Charles and Marjorie Holloway Foundation

Ovarian Cancer Research Fund

MIT

Koch Institute

American Cancer Society

National Cancer Institute

Center for Environmental Health

Publisher

Elsevier BV

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference92 articles.

1. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr,2010

2. Spatial exclusivity combined with positive and negative selection of phosphorylation motifs is the basis for context-dependent mitotic signaling;Alexander;Sci. Signal.,2011

3. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo;Alexandre;Int. J. Cancer,2006

4. Polo-like kinases: conservation and divergence in their functions and regulation;Archambault;Nat. Rev. Mol. Cell Biol.,2009

5. 8-oxoguanine DNA glycosylase 1: beyond repair of the oxidatively modified base lesions;Ba;Redox Biol.,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the nucleic acid oxidative damage repair enzyme MTH1: a promising therapeutic option;Frontiers in Cell and Developmental Biology;2024-01-31

2. FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy;Cell Reports;2023-08

3. Performance evaluation of drug synergy datasets using computational intelligence approaches;Multimedia Tools and Applications;2023-06-19

4. Mitotic MTH1 Inhibitors in Treatment of Cancer;Targeting the DNA Damage Response for Cancer Therapy;2023

5. Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling;Cancer Research;2022-11-21